Grogan, J;Shou, M;Andrusiak, E A;Tamura, S;Buters, J T;Gonzalez, F J;Korzekwa, K R
Cytochrome P450 2A1, 2E1, and 2C9 cDNA-expression by insect cells and partial purification using hydrophobic chromatography.
Biochem Pharmacol
1995
50
9
1509-15

Buters, J T;Shou, M;Hardwick, J P;Korzekwa, K R;Gonzalez, F J
cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.
Drug Metab Dispos
1995
23
7
696-701

Crespi, C L;Steimel, D T;Penman, B W;Korzekwa, K R;Fernandez-Salguero, P;Buters, J T;Gelboin, H V;Gonzalez, F J;Idle, J R;Daly, A K
Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374.
Pharmacogenetics
1995
5
4
234-43

Wosikowski, K;Regis, J T;Robey, R W;Alvarez, M;Buters, J T;Gudas, J M;Bates, S E
Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
Cell Growth Differ
1995
6
11
1395-403

Gelboin, H V;Krausz, K W;Goldfarb, I;Buters, J T;Yang, S K;Gonzalez, F J;Korzekwa, K R;Shou, M
Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4.
Biochem Pharmacol
1995
50
11
1841-50